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ABSTRACT  
Crataeva adansonii DC. ssp. adansonii is a medicinal plant belong to Capparidaceae family, used traditionally by Togolese to treat diabetes 
mellitus. The aim of this study was to evaluate the antihyperglycaemic and antioxidant activities of the plant leaves. The effect of hydroethanolic 
extract of C. adansonii ssp. adansonii leaves was assessed in vivo on blood glucose levels in fasting normal and glucose loaded hyperglycemic 
(oral glucose tolerance test) mice. The phytochemical screening has been done by coloring tests in chemistry. In vitro antioxidants assays had 
been performed by 2, 2'-azobis 2 amidinopropane dihydrochloride (AAPH) free radical scavenging assay, Ferric reducing antioxidant power 
(FRAP) assay, Fe2+ chelating assay and total antioxidant capacity (TAC) quantification. After 30 min glucose loading (4 g/kg), the extract 500 
mg/kg was showed a significant (p < 0.001) decreased of the peak of blood glucose compared to the hyperglycemic control. The two doses of 
extract (250 and 500 mg/kg) did not act on the basic blood glucose compared to the normoglycemic control. Phytochemical scree ning revealed 
a presence of flavonoids, tannins, alkaloids and sterols. AAPH free radical scavenging activity, reducing power, Fe2+ chelating activity and total 
antioxidant capacity have shown dose-dependent antioxidant capacity and reducing power of extract compared to ascorbic acid and Butylated 
hydroxyl Toluene used as reference drug. These finding prove that C. adansonii ssp. adansonii leaves can be used in the treatment of diabetes 
mellitus and its complications related to oxidative stress and support the use of the plant in traditional medicine in diabetes treatment.   
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INTRODUCTION 
Diabetes is a metabolic disease that is nowadays a major 
public health problem and has significant economic 
consequences in the treatment of its complications. It 
characterized by a high hyperglycemia and diagnosed by 
fasting blood glucose ≥ 126 mg/dl (7 mmol/l) or ≥ 200 
mg/dL (11.1 mmol/l) after oral glucose tolerance test [1]. 
This high chronicle hyperglycemia result to the defect in 
insulin secretion, it action or both combined anomalies. 
Diabetes can be ranked in four types: diabetes type 1, 
common in children and young people (5 to 10% of cases); 
diabetes types 2, observed in adults (90 to 95% of cases); 
pregnancy diabetes which touch 3 to 20% of the pregnant 
women; in end others types of diabetes due to various 
reasons [1, 2]. The two meanly type of diabetes mellitus result 
on the progressive loss of pancreatic β-cell by autoimmune 
processes following deficiency in insulin (type 1 diabetes) 
and a decreased sensitivity of insulin receptors to insulin 
and pancreatic β-cell dysfunction which leads to insulin 
resistance (type 2 diabetes). Whatever the type of diabetes, 
there is a hyperglycemia that untreated causes 
complications. The prevalence of the disease is increasing 
and it mainly due to the aging of population and lifestyle like 
sedentary and eating habits. According to the International 
Diabetes Federation (IDF), the prevalence of diabetes was 
8.8% in 2017 and will be 9.9 in 2045 if nothing is made [2]. In 
the worldwide, every 6 seconds about 1 person dies of 
diabetes and most of them occur in low- and middle-income 
countries. In Africa, 4.4% of adults had diabetes and this 
prevalence reached 6.2% for Togo in 2017 [2].  
In fact, diabetes complications can be avoided or retarded 
while normalizing as possible the blood glucose level, the 
arterial pressure and the blood cholesterol level. In 
conventional medicine, oral hypoglycemic agents and some 
insulin gave their proofs, but are not without side effects. 
Besides, the cost of diabetes treatment is out of the range of 
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some patient. These situations bring patients to turn toward 
the traditional medicine for alternative care. The use of the 
plants in traditional medicine dates for very long and they 
have needed to be studied to bring the scientific proofs to 
their efficiency. Crataeva adansonii DC. is one of antidiabetic 
plant belonging to Capparidaeae family and commonly called 
sacred garlic pear or temple plant. In traditional 
pharmacopeia, the plant is used as astringent and treats 
affections such as urinary, renal tubules, uterine, gastro-
intestinal, skin, inflammatory, asthma and snakebites [3, 4]. In 
Togo, the plant is consumed as a legume and traditionally 
used to treat diseases such as abscesses, wounds, bacterial 
infections, rheumatism and diabetes. Previously studies 
have reported antimicrobial, anticancer, antiparasitic, 
analgesic, antioxidant, antidiabetic and antihypertension 
activities of C. adansonii [5, 6]. Despite the widespread use of 
C. adansonii, scientific data on its antidiabetic properties are 
very paucity. This study aimed to determine the antidiabetic 
properties of C. adansonii DC. ssp. adansonii and to prove its 
use in traditional pharmacopoeia.  
MATERIALS AND METHODS 
Plant material 
The leave of C. adansonii spp. adansonii is used as plant 
material. It has been collected in 4th district at Nyekonakpoe 
(Lome city, Togo). The plant materiel was identified at 
Botany and Plant Ecology Laboratory (Faculty of 
Science/University of Lomé) where voucher specimen was 
deposited in the herbarium as herbarium specimen No. 
15190. The leaves of the plant were dried at 25 ± 2 °C in safe 
from light for two week and then reduce in powder.  
Animals  
The animal material consists of ICR mice weighing 25 ± 5 g. 
They have been provided by Laboratory of Animal 
Physiology (Faculty of the Sciences/University of Lome) and 
have been kept in cages under standard environmental 
conditions with free access to water and food. In vivo test on 
mice was conducted in accordance with institutional 
guidelines and ethics of Laboratory of Physiology-
Pharmacology of University of Lome-Togo referred as 
001/2012/ CB-FDS-UL. 
Extraction 
C. adansonii leaves powder (400 g) was macerated in 4 liter 
of mixture of ethanol-water (70: 30) for 72 h. The macerate 
was filtered on hydrophilic cotton and then on Wattman 
paper No. n°40 (Ø150 mm) and evaporated to dryness at 45 
°C using a rotary evaporator under vacuum (Büchi 
Rotavapor R210, Germany). The resulting dry extract was 
collected in a sterile glass vial and placed in a desiccator for 
24 h and then stored in the refrigerator at 4-8 °C. 
Effect of extract on mice hyperglycemic  
Oral glucose tolerance test (OGTT) was used to induce 
hyperglycemia. Mice were fasted (7 h) and blood glucose 
was measured before to administrate all solutions. Animals 
were divided into 5 groups of 5 mice each. Hyperglycemic 
control received distilled water (5 mL/kg), treated groups 
received extracts 250 and 500 mg/kg and reference groups 
received metformin 100 mg/kg by gavage 30 minutes before 
glucose overload (4 g/kg body weight) at rate of 5 mL/kg. 
Normoglycemic controls received only distilled water (no 
glucose overload). Blood glucose levels were measured from 
the tail vein blood of mice using One Touch Ultra Glucometer 
(USA) during 180 min (0 min before and 30 min, 60 min, 120 
min, 180 min after glucose loading). 
 
Effect of extract on mice basic blood glucose  
Mice were divided into 4 groups (5 mice each). 
Normoglycemic controls group received only distilled water 
(5 mL/kg body weight), treated groups received extract 
(250 and 500 mg/mL) and reference groups received 
metformin (100 mg/mL). Blood glucose levels were 
measured at the tail vein on 180 min (0 min before and 30 
min, 60 min, 90 min, 120 min, 180 min after administration 
the solutions by gavage). 
Phytochemical screening  
Qualitative phytochemicals analyses were sought in the 
extracts by coloring tests in chemistry [7, 8]. The presence of 
alkaloids was performed by Mayer and Bouchardat reaction; 
tannins by FeCl3 2% reaction; flavonoids by NaOH N/10 and 
FeCl3  reaction; reducing compounds by Molish, Keller-
Killiani and Fehling reaction; saponins by foams test; in end 
sterols and terpenes by Liebermann-Buchard reacion. 
Total phenols and tannins contents 
Principle: All the phenolic compounds of the extract were 
oxidized by the Folin-Ciocalteu reagent (a mixture of 
phosphotungstic acid (H3PW12O40) and phosphomolybdic 
acid (H3PMo12O40)) which is reduced during the oxidation of 
the phenols in a mixture of blue oxides of tungsten (W40O23) 
and molybdenum (Mo8O23). The resulting blue color absorbs 
around 750 nm. Fixing tannins by polyvinylpolypyrrolidone 
(PVPP) made it possible to deduce their quantity of the total 
phenols after a second dosage [9, 10]. The test was performed 
by adding 200 μL of Folin-C 10% reagent to 200 μL of extract 
(1 mg/mL in methanol 95%) or to 200 μL of supernatant of 
PVPP-fixed extract solution (previously fixed tannins by 
adding 500 µL of extract to 10 mg of PVPP dissolve in 500 µL 
of methanol 95%) and incubated at 28 ± 2 °C for 15 min. 
After incubation, 800 μL of sodium carbonate solution (700 
mM) were added and absorbance was measured at 735 nm 
against blank. Gallic acid (GA) (0; 25; 50; 100; 150; 100 
μg/mL) was used as standard to generate the calibration 
curve. Tannins have been subtracted from total phenols by 
differentiating optical densities (OD): ODtanins = ODextract - 
ODextract+PVP. Total phenol and tannins were expressed as mg 
equivalence of GA/g of extract. 
Total flavonoids content 
The flavonoids contained in the extract were determined by 
the aluminum chloride (AlCl3) method [9, 11]. In principle, 
flavonoids form with alumina chloride a flavonoid-
aluminum complex that absorbs at 440 nm. The test was 
performed by adding 2 mL of AlCl3 (20 mg/mL in distilled 
water) and 6 mL of sodium acetate (50 mg/mL in distilled 
water) to 2 mL of extract (1 mg/mL in methanol). Mixed and 
incubated at laboratory temperature for 2 h 30 min. The 
absorbance was measured at 440 nm against blank. Rutin (1; 
5; 25; 50; 100 μg/mL) was used as standard to generate the 
calibration curve. The total flavonoids were expressed in mg 
of equivalence of Rutin/g of extract.  
In vitro antioxidant assays 
Total antioxidant capacity (TAC) assay 
The principle is based on the reduction of molybdenum ion 
Mo (+6) in Mo (+5) by the extract and the subsequent 
formation of the phosphate-Mo (+5) green complex at acidic 
pH. The test was performed by adding 3 mL of reagent 
(Sulfuric acid 0.6 M, sodium phosphate 28 mM and 
ammonium molybdate 4 mM) to 0.3 mL of extract (1 
mg/mL) prepared in methanol. It was incubated at 95 °C for 
90 min and then brought back to laboratory temperature. 
Absorbance was measured at 695 nm against blank [12]. For 
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the blank, extract was replaced by methanol. Ascorbic acid 
(31.25; 62.5; 125; 250 μg/mL) was used as standard to 
generate the calibration curve. The total antioxidant capacity 
was expressed as mg equivalence of ascorbic acid/g of 
extract. 
Ferric reducing antioxidant power (FRAP) 
The principle is based on the reaction of reducing 
compounds with ferric potassium cyanide (Fe3+) to form 
ferrous potassium cyanide (Fe2+) which reacts with ferric 
chloride to form ferrous-ferric complex that has a maximum 
absorbance at 700 nm. The test was performed by mixing 
2.5 mL of phosphate buffer (0.2 M; pH 6.6) and 2.5 mL of 
potassium ferricyanide (1%) with 0.5 mL of extract (50; 100; 
200; 400; 800 μg/mL) prepared in methanol. The mixture 
was incubated at 50 °C for 20 min and then, 2.5 mL of 
trichloroacetic acid 10% was added and centrifuged at 3000 
rpm for 10 min. To 2.5 mL of supernatant, 2.5 mL of distilled 
water and 0.5 mL of iron chloride 0.1% were added 
successively. Ascorbic acid and Butylated hydroxyl Toluene 
(BHT) was used as reference antioxidant. Absorbance was 
measured at 700 nm [9, 13]. The intensity of the absorbance 
indicates the intensity of the reducing power. 
AAPH free radical scavenging assay 
In the principle, the decomposition of 2, 2'-azobis 2 
amidinopropane dihydrochloride (AAPH) generates free 
radicals at constant speed that attack the red blood cells 
membrane. When there is no more endogenous antioxidant, 
the membrane of the red blood cells burst and the 
hemoglobin is found in the supernatant. The addition in the 
medium of molecules or extracts with antioxidant properties 
delays the onset of hemolysis. The test was performed by 
bringing 250 µL of red blood cells (washed in PBS) and 250 
µL of AAPH in contact of 250 µL of extract (50; 100; 150; 
200; 250 μg/mL). After incubated for 3 h, at 37 °C, 4 mL of 
PBS (phosphate buffered solution) was added and then 
centrifuged at 1000 g for 10 min. Absorbance was measured 
at 540 nm [9, 14]. For control extract was replaced by PBS. 
Ascorbic acid was used as reference antioxidant. Inhibition 
 % = . 
Metal (Fe2+) chelating activity assay 
The method is based on the ability of extracts to chelate Fe2+ 
ions [15]. The test was performed by adding 50 μL of FeCl2 (2 
mmol/l) to 0.5 mL of extract (50; 100; 150; 200; 250 
μg/mL). The reaction was initiated with 200 μL of ferrozine 
(5 mmol/l) and then stirred vigorously. After incubated 10 
min at room temperature (28 ± 2 °C), the absorbance was 
measured at 562 nm. Ethylenediaminetetraacetic acid 
(EDTA) was used as reference antioxidant. For control, 
extract was replaced by methanol.  
Ferrozine-Fe2+ inhibition % = . 
Statistical analyzes 
Data were expressed as mean ± SEM (standard error of the 
mean) using the GraphPad Prism 6 software. Statistical 
differences between treated groups and controls were 
determined by 2ways ANOVA and considered significant for 
p < 0.05. 
RESULTS AND DISCUSSION  
RESULTS 
Effect of extract on mice oral glucose tolerance test 
(OGTT) 
After 30 min glucose overload, the blood glucose increased 
significantly to reach a peak before decreasing. This increase 
of glycaemia was significant at t30 (p < 0.001), t60 (p < 
0.001), and t120 (p < 0.05). During this time, blood glucose 
levels increased to 129.98% (from 93.400 ± 7.082 to 
214.800 ± 7.813 mg/dL) at t30 before remained nearly to 
the normal around 180 min (Figure 1A). The area under the 
curve (AUC) of glucose tolerance, which measured the total 
amount of available glucose in the blood, also showed a 
significant (p < 0.001) increase (72.04%) in blood glucose 
levels in OGTT mice (AUCHC = 25749 min.mg/dL) when 
compared to normoglycemic control (AUCNC = 14967 
min.mg/dL) (Figure 1B). 
The administration of extract 30 min prior to OGTT, 
significantly prevented the rise in blood glucose in the fasted 
mice when compared to the hyperglycemic controls. The 
extract 250 mg/kg body weight did not cause a significant 
decrease in blood glucose during the 180 min. By vs, the 
extract 500 mg/kg body weight caused a significant decrease 
in blood glucose over the same time. This decrease was 
32.31% (p < 0.001) at t30; 55.86% (p < 0.001) at t60 and 
42.72% (p < 0.01) at t120. At t180, this decrease is no longer 
significant. Metformin 100 mg/kg, used as a reference drug, 
significantly reduced blood glucose at time t30 (28.68%; p < 
0.001) and t60 (26.39%; p < 0.01) (Figure 1A). AUCs of 
glucose tolerance showed a significant decrease for both 
doses of extract and Metformin. Blood glucose decreased to 
14.67% (p < 0.05) for extract 250 mg/kg; to 40.77% (p < 
0.001) for extract 500 mg/kg and to 20.85% (p < 0.01) for 
metformin 100 mg/kg (Figure 1B). 
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Effect of extract on basal blood glucose 
The administration of extract at doses of 500 and 250 mg/kg 
did not result in a significant decrease in the basal glycaemia 
of the mice when compared to the normoglycemic control 
whose blood glucose level oscillated around the initial value 
(77.800 ± 4.176 mg/dL) during the 180 min. The reference 
drug, metformin 100 mg/kg, did not significantly decrease 
basal blood glucose (Figure 2A). AUCs also remained without 
significant difference (Figure 2B). 
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Figure 1: Effects of C. adansonii extract on oral glucose tolerance 
(A = Blood glucose level vs time, B = Area under the curve (AUC) of blood glucose) 
Blood glucose was measured for 180 min at different time: t0 = 0 min, corresponds to basal blood glucose level of the 
fasted mice and t30; t60; t120; t180 correspond to 30; 60; 120 and 180 min after glucose overload. HC = 
hyperglycemic controls; NC = Normoglycemic controls; Extract 250, 500 = extract 250 and 500 mg/kg; Met 100 = 
metformin 100 mg/kg. The values are expressed in means ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001 compared to 
HC and NC. n = 5. 
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Figure 2: Effects of C. adansonii extract on basal glucose 
(A = Blood glucose level vs time, B = Area under the curve (AUC) of blood glucose) 
Blood glucose was measured for 180 min at different time: t0 = 0 min, corresponds to the measurement of the basal 
blood glucose level of the fasted mice and t30; t60; t120; t180 correspond to 30; 60; 120 and 180 min after 
administration of distilled water (NC), extracts 500 and 250 mg/kg and Met 100. NC = normoglycemic controls; Met 
100 = metformin 100 mg/kg. The values are expressed in means ± SEM. * p < 0.05; ** p < 0.01; ***; p < 0.001 
compared to NC. n = 5. 
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Phytochemical screening 
Table 1: Phytochemical groups present in extract 
Phytochemical compounds and Reagents Results 
Alkaloids identification 
Mayer 
Bouchardat 
 
+ 
+ 
Tannins identification 
FeCl3 2% 
 
+ 
Flavonoids identification 
NaOH N/10 
FeCl3 
 
+ 
+ 
Saponins identification 
Agitation 
Liebermann-Buchard 
 
+ 
+ 
Reducing compound and sugar identification 
Liqueur de Fehling 
Molish 
Keller-Killiani 
 
- 
+ 
+ 
+ = presence        - = absence 
 
Qualitative phytochemical analysis revealed a presence of flavonoids, tannins, alkaloids, saponosides and sterols. Reducing 
compounds are in trace (Table 1). 
 
Phenolic compound content in extract 
Total phenols and tannins are determined from Gallic Acid 
calibration curve; while flavonoids from Rutin calibration 
curve (Figure 3). The phenolic compounds contained in 
extract were presented in table 2.  
 
Table 2: Phenols compounds and total antioxidant capacity content in extract 
Total Phenols (mg GAE/g) Tannins (mg GAE/g) Flavonoids (mg RE/g) TAC (mgAAE/g)  
184.330 ± 0.289 80.539 ± 0.577 116.765 ± 0.766 602.667 ± 4.807 
 
Flavonoids were highly in C. adansonii leaves than tannins: 63.35% vs 43.69% of total phenolic compounds (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In vitro antioxidant activities of C. adansonii leaves   
Total antioxidant capacity 
When increasing concentration of standard, the antioxidant 
capacity increases positively and is correlated with 
increasing of absorbance (Figure 4). The TAC value indicates 
in table 2 represent all antioxidant compounds present in 
the extract as equivalence of ascorbic acid which act in 
hydrophilic and lipophilic part. 
 
               A                                                           B 
Figure 3: Total phenols and flavonoids determination  
A = Gallic Acid calibration curve for total phenols and tannins determination. B = Rutin calibration curve for 
flavonoids determination. Values are expressed in means ± SEM. ; n = 3. 
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Reducing power 
The absorbance of extract and controls increase dose-depending and indicate an increase of reducing power. However, the 
absorbance of the extract is lower than that of controls (BHT and AA) (Figure 5). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
AAPH free radical scavenging 
C. adansonii delays dose-depending the red blood cells 
hemolysis by scavenging the free radicals generated by 
AAPH. Inhibition of hemolysis results in a decrease in 
absorbance. Therefore, extract showed a higher activity than 
ascorbic acid (AA) used as reference drug (Figure 6). The 
inhibitory concentration 50% of extract was presented in 
table 3.  
The table 3 showed that extract inhibitory concentration 
50% is lower than that of AA. This means that a small 
concentration of extract would achieve the same levels of 
free radical scavenging given by AA. 
 
 
Table 3: Concentration inhibiting 50% AAPH free radical and Ferrozine-Fe2+ complex 
*IC50 (µg/mL)  Extract   Ascorbic Acid  EDTA 
AAPH free radical scavenging  110 ± 2.764  170 ± 3.021 - 
Fe2+ chelating 162 ± 1.684 - 227 ± 2.043 
*IC50 = Inhibitory concentration 50% 
Figure 4: Ascorbic Acid calibration curve for TAC determination. 
Values are expressed in means ± SEM. ; n = 3. 
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Figure 5: Reducing power of extract compared to BHT and AA. 
BHT = Butylated hydroxyl Toluene. AA= Ascorbic Acid Values are expressed in means 
± SEM. ; n = 3. 
C o n c e n tra tio n  (µ g /m L )
A
b
s
o
rb
a
n
c
e
 a
t 
7
0
0
 n
m
0 2 0 0 4 0 0 6 0 0 8 0 0
0 .0
0 .5
1 .0
1 .5
2 .0
2 .5
A A
B HT
E x tra c t
Atchou et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2020; 10(1-s):30-38 
ISSN: 2250-1177                                                                                  [36]                                                                                 CODEN (USA): JDDTAO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fe2+ chelating activity 
Inhibition of Ferrozine-Fe2+ complex formation results in a 
decrease in absorbance. As the concentration increases, the 
absorbance of extract and EDTA decrease. The absorbances 
of the extract were lower than that of EDTA and therefore 
indicate a higher activity of the extract (Figure 7). The 
extract IC50 confirmed that significant decreased absorbance 
(Table 4). 
 
Table 4: Concentration inhibiting 50% AAPH free radical and Ferrozine-Fe2+ complex 
*IC50 (µg/mL)  Extract   Ascorbic Acid  EDTA 
AAPH free radical scavenging  110 ± 2.764  170 ± 3.021 - 
Fe2+ chelating 162 ± 1.684 - 227 ± 2.043 
*IC50 = Inhibitory concentration 50% 
Extract IC50 < EDTA IC50, that mean the chelating Fe2+ compounds are highly present in the extract when compared to EDTA 
(Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: AAPH free radical scavenging activity of extract compared to 
ascorbic acid (AA) 
Values are expressed in means ± SEM. ; n = 3. 
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Figure 7: Fe2+ chelating activity of extract compared to EDTA 
EDTA = ethylenediamineteraacetic acid. Values are expressed 
in means ± SEM; n = 3 
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DISCUSSION  
The ethnobotanical survey conducted among traditional 
healers of Lome city (Togo) made it possible to select from 
the list of plants used in the treatment of diabetes, Crateva 
adansonii. This plant has been evaluated in this study for its 
antihyperglycemic and antioxidant properties. 
Oral hyperglycemia on fasting mice resulted in a significant 
(p < 0.001) increase in blood glucose. Absorbed glucose 
passed into the general circulation and raised blood glucose; 
which explains the peak observed at time t = 30 min. Under 
the action of insulin, the cells responsible for capturing 
glucose have been sensitized to use and store it as glycogen 
in the liver mainly [16]. These mechanisms explain the 
gradual decrease in blood glucose levels until homeostasis is 
reached around 180th min. 
Administration of the hydroalcoholic extract of C. adansonii 
leaves at doses of 250 mg/kg and 500 mg/kg body weight 
prior to on mice OGTT prevented the increase in blood 
glucose. Only the extract at the dose of 500 mg/kg cause a 
significant decrease in mice blood glucose during the 180 
min (p < 0.001 at 30 min). This action of extract 500 mg/kg 
was more important than that of metformin used as a 
reference. The glucose available in the blood per unit of time 
determined by AUC confirmed this reduction in blood 
glucose by the extract. This demonstrates the presence in 
the extract of antihyperglycaemic compounds that could 
have resulted in a more marked biological effect at a dose of 
500 mg/kg. The extract would have acted thus by delaying 
or blocking the intestinal absorption of glucose or by 
sensitizing peripheral tissues to capture glucose or store it 
primarily as glycogen [16, 17]. 
The two doses of tested extract did not result in a significant 
decrease in mice basal blood glucose over the 180 min. This 
suggested that the leaf of C. adansonii extract does not 
directly affect insulin secretion. The action of C. adansonii 
extract 500 mg/kg is then similar to that of metformin which 
has an antihyperglycaemic effect, but no hypoglycaemic 
power (not act on the basal blood glucose). Indeed, 
metformin is a molecule belonging to biguanid class, which 
decreases gastrointestinal carbohydrates absorption and 
inhibits hepatic neo-glucogenesis by activating an 
intracellular route via AMP-activated protein kinase (AMPK). 
Metformin also increases peripheral tissues sensitivity to 
insulin and the uptake of glucose; it does not induce an 
increase in insulin secretion [18]. The administration of the 
extract 500 mg/kg may therefore make it possible to avoid 
postprandial hyperglycemia in diabetics. 
The antihyperglycaemic activity of C. andansonii extract is 
believed to be active in certain phytochemical compounds. 
Qualitative and quantitative phytochemical analyzes 
revealed a high presence of flavonoids and tannins. These 
two polyphenolic compounds would have acted alone or in 
synergy with other compounds to give the observed 
antihyperglycaemic effect [19, 20].  
Furthermore, oxidative stress is an important factor in the 
onset of diabetes. It leads to the production of free radicals 
that induce membrane lipids peroxidation and cause damage 
to tissues and DNA. Reactive oxygen species (ROS) 
production mainly depends on two factors: mitochondrial 
oxidative phosphorylation and NADPH oxidase system [21, 22]. 
Mitochondria are indeed the main endogenous source of 
ROS and can use 95% available oxygen to produce ATP. 
About oxygen 2% enters the electron transport chain; then it 
is oxidized to superoxide (O2-) and hydrogen peroxide 
(H2O2). In diabetes, the decoupling of mitochondrial electron 
transport leads to excessive production of superoxide that 
can stimulate several abnormal biochemical metabolic 
pathways and increase the production of nitric oxide (NO) 
resulting in DNA damage [9, 22, 23]. As a result, we have 
vascular endothelium dysfunction which contributes to the 
development of cardiovascular disease [24]. The NADPH 
oxidase system can also generate ROS and catalyze 
molecular oxygen to produce O2- and/or H2O2 by accepting 
electrons from NADPH and transporting them to molecular 
oxygen. Antioxidant administration can therefore reduce the 
oxidative stress and excessive production of NO caused by 
hyperglycemia. The antioxidant capacity and the reducing 
power of the plant extract can help to reduce membranes 
lipids peroxidation and ROS regeneration by the NADPH 
oxidase system. Otherwise, the antioxidant and reducing 
power of the extract can be explained by the presence of 
flavonoids and tannins that interact directly with activated 
oxygen species to inhibit the formation of free radicals [25]. 
The total antioxidant compounds present in extract highlight 
by TAC essay, would have acted in the hydrophilic and 
lipophilic part. This quantification showed that the leaf 
extract of C. adansonii is rich in antioxidant compounds and 
can be used to prevent or delay diabetes complications by 
reducing ROS generated by glucose oxidation. 
CONCLUSION 
In vivo evaluation of C. adansonii ssp. andansonii leaves 
extract on oral glucose tolerance and basal blood glucose in 
mice showed that the plant had an antihyperglycaemic effect 
and can be used to reduce hyperglycemia during diabetes. 
The plant extract at a dose of 500 mg/kg body weight 
significantly reduced the blood glucose level without 
lowering basal glucose level. Phytochemical screening 
revealed a high presence of phenolic compounds such as 
flavonoids and tannins that could be responsible for the 
observed antihyperglycaemic activity. These phytochemicals 
compounds would have acted alone or in synergy. In 
addition, the extract of the plant has an antioxidant and 
reducing power and can be used for this purpose in the 
treatment of diabetes complications related to oxidative 
stress. 
The finding showed that C. adansonii ssp. andansonii leaves 
can be used in the treatment of non-insulin-depending 
diabetes and its complications. This justifies the use of the 
leaves of the plant in traditional medicine. However, further 
studies are needed to elucidate the mechanisms of action of 
active compounds, to evaluate the toxicity and then to 
standardize the doses of extract to be administered in order 
to produce traditionally improve drugs. 
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